Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
2015 · Nature Communications · 298 citations
https://doi.org/10.1038/ncomms7169
B
Biswanath Majumder
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
1.7K
Citations
20
h-index
25
i10-index
Biswanath Majumder is an academic researcher from National Centre for Biological Sciences. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics & HIV Research and Treatment. The author has an h-index of 20, co-authored 58 publications.
Papers by this author
worksTemporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
2015 · Nature Communications · 284 citations
https://doi.org/10.1038/ncomms7139
Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2
2017 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-017-01566-x
Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer
2023 · iScience · 15 citations
https://doi.org/10.1016/j.isci.2023.108395
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat